RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
In vitro-in vivo correlation (IVIVC) population modeling for the in silico bioequivalence of a long-acting release formulation of Progesterone
2018-01-01 Tosca, E. M.; De Nicolao, G.; Rochetti, M.; Magni, P.; Perez, E.; Nieto, C.; Bettica, P.; Moscoso del Prado, J.
Integrating Reinforcement Learning and PK-PD modelling to enable precision dosing: a multi-objective optimization for the treatment of Polycithemia Vera patients with Givinostat
2023-01-01 De Carlo, A.; Tosca, E. M.; Magni, P.
Landscape on technical and conceptual requirements in Drug/Disease Modelling & Simulation
2012-01-01 G., Vlasakakis; E., Comets; A., Drescher; I., Gueorguieva; Magni, Paolo; Terranova, Nadia; O., Della Pasqua; E. C., de Lange; C., Kloft
Mathematical models of tumor growth inhibition in xenograft mice after administration of anticancer agents given in combination
2013-01-01 Terranova, Nadia; Germani, MASSIMILIANO ENRICO; DEL BENE, Francesca; Magni, Paolo
Mechanistic multi-scale systems pharmacokinetics model applied for the anticancer drug Gemcitabine in pancreatic cancer
2017-01-01 Garcia Cremades, M.; Melillo, Nicola; Magni, Paolo; Troconiz, I. F.
Methods and tools for multiscale modelling in Systems Pharmacology: a review
2016-01-01 Borella, Elisa; Carrara, Letizia; Lavezzi, SILVIA MARIA; Massaiu, Ilaria; Sauta, Elisabetta; Tosca, ELENA MARIA; Vitali, Francesca; Zucca, Susanna; Pasotti, Lorenzo; DE NICOLAO, Giuseppe; Magni, Paolo
Model Description Language (MDL) - a standard for model communication and interoperability
2016-01-01 Smith, Mk; Moodie, S; Bizzotto, R; Blaudez, E; Borella, Elisa; Carrara, Letizia; Chan, P; Chenel, M; Comets, E; Gieschke, R; Harling, K; Harnisch, L; Hartung, N; Hooker, A; Karlsson, Mo; Kaye, R; Kloft, C; Kokash, N; Lavielle, M; Magni, Paolo; Mari, A; Mentre, F; Muselle, C; Nordgren, R; Nyberg, H; Parra Guillen, Zp; Pasotti, Lorenzo; Rode Kristensen, N; Smith, G; Swat, Mj; Terranova, Nadia; Yvon, F; Holford, NICHOLAS HUGH GEORGE
Model-based analysis of patient-derived organoids for evaluating anticancer drugs
2023-01-01 Ronchi, D.; Tosca, E. M.; De Siervi, S.; Turato, C.; Lolicato, M. G.; Magni, P.
Model-based comparison of alternative study designs in paediatric trials
2015-01-01 Smania, Giovanni; Baiardi, P.; Cella, M.; Magni, Paolo
Modeling resistance development to Bevacizumab in xenograft experiments by coupling hypoxia-mediated mechanism and a Dynamic Energy Budget (DEB) based tumor-in-host model
2018-01-01 Tosca, E.; Rocchetti, M.; Pesenti, E.; Magni, P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| In vitro-in vivo correlation (IVIVC) population modeling for the in silico bioequivalence of a long-acting release formulation of Progesterone | 1-gen-2018 | Tosca, E. M.; De Nicolao, G.; Rochetti, M.; Magni, P.; Perez, E.; Nieto, C.; Bettica, P.; Moscoso del Prado, J. | |
| Integrating Reinforcement Learning and PK-PD modelling to enable precision dosing: a multi-objective optimization for the treatment of Polycithemia Vera patients with Givinostat | 1-gen-2023 | De Carlo, A.; Tosca, E. M.; Magni, P. | |
| Landscape on technical and conceptual requirements in Drug/Disease Modelling & Simulation | 1-gen-2012 | G., Vlasakakis; E., Comets; A., Drescher; I., Gueorguieva; Magni, Paolo; Terranova, Nadia; O., Della Pasqua; E. C., de Lange; C., Kloft | |
| Mathematical models of tumor growth inhibition in xenograft mice after administration of anticancer agents given in combination | 1-gen-2013 | Terranova, Nadia; Germani, MASSIMILIANO ENRICO; DEL BENE, Francesca; Magni, Paolo | |
| Mechanistic multi-scale systems pharmacokinetics model applied for the anticancer drug Gemcitabine in pancreatic cancer | 1-gen-2017 | Garcia Cremades, M.; Melillo, Nicola; Magni, Paolo; Troconiz, I. F. | |
| Methods and tools for multiscale modelling in Systems Pharmacology: a review | 1-gen-2016 | Borella, Elisa; Carrara, Letizia; Lavezzi, SILVIA MARIA; Massaiu, Ilaria; Sauta, Elisabetta; Tosca, ELENA MARIA; Vitali, Francesca; Zucca, Susanna; Pasotti, Lorenzo; DE NICOLAO, Giuseppe; Magni, Paolo | |
| Model Description Language (MDL) - a standard for model communication and interoperability | 1-gen-2016 | Smith, Mk; Moodie, S; Bizzotto, R; Blaudez, E; Borella, Elisa; Carrara, Letizia; Chan, P; Chenel, M; Comets, E; Gieschke, R; Harling, K; Harnisch, L; Hartung, N; Hooker, A; Karlsson, Mo; Kaye, R; Kloft, C; Kokash, N; Lavielle, M; Magni, Paolo; Mari, A; Mentre, F; Muselle, C; Nordgren, R; Nyberg, H; Parra Guillen, Zp; Pasotti, Lorenzo; Rode Kristensen, N; Smith, G; Swat, Mj; Terranova, Nadia; Yvon, F; Holford, NICHOLAS HUGH GEORGE | |
| Model-based analysis of patient-derived organoids for evaluating anticancer drugs | 1-gen-2023 | Ronchi, D.; Tosca, E. M.; De Siervi, S.; Turato, C.; Lolicato, M. G.; Magni, P. | |
| Model-based comparison of alternative study designs in paediatric trials | 1-gen-2015 | Smania, Giovanni; Baiardi, P.; Cella, M.; Magni, Paolo | |
| Modeling resistance development to Bevacizumab in xenograft experiments by coupling hypoxia-mediated mechanism and a Dynamic Energy Budget (DEB) based tumor-in-host model | 1-gen-2018 | Tosca, E.; Rocchetti, M.; Pesenti, E.; Magni, P. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 61
- 1 Contributo su Rivista::1.5 Abst... 61
Data di pubblicazione
- 2020 - 2023 12
- 2010 - 2019 43
- 2003 - 2009 6
Editore
- ISMB/ECCB 1
Rivista
- PAGE 51
- JOURNAL OF PHARMACOKINETICS AND P... 3
- CPT: PHARMACOMETRICS & SYSTEMS PH... 2
- BLOOD 1
- CIRCULATION RESEARCH 1
- JOURNAL OF PHARMACOLOGICAL AND TO... 1
- NEW BIOTECHNOLOGY 1
Keyword
- drug development 24
- pharmacokinetic-pharmacodynamic m... 20
- Mathematical modelling of biologi... 15
- Mathematical modeling 14
- preclinical studies 13
- pharmacokinetics and pharmacodyna... 10
- Mathematical models of biological... 7
- oncology drugs 6
- pharmacometrics 6
- anticancer drug 5
Lingua
- eng 58
Accesso al fulltext
- no fulltext 61